Literature DB >> 19640227

Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

Judith A Aberg1, Jonathan E Kaplan, Howard Libman, Patricia Emmanuel, Jean R Anderson, Valerie E Stone, James M Oleske, Judith S Currier, Joel E Gallant.   

Abstract

Evidence-based guidelines for the management of persons infected with human immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America. These updated guidelines replace those published in 2004. The guidelines are intended for use by health care providers who care for HIV-infected patients or patients who may be at risk for acquiring HIV infection. Since 2004, new antiretroviral drugs and classes have become available, and the prognosis of persons with HIV infection continues to improve. However, with fewer complications and increased survival, HIV-infected persons are increasingly developing common health problems that also affect the general population. Some of these conditions may be related to HIV infection itself and its treatment. HIV-infected persons should be managed and monitored for all relevant age- and gender-specific health problems. New information based on publications from the period 2003-2008 has been incorporated into this document.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640227     DOI: 10.1086/605292

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  137 in total

1.  The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV.

Authors:  Gary W Harper; Isabel M Fernandez; Douglas Bruce; Sybil G Hosek; Robin J Jacobs
Journal:  AIDS Behav       Date:  2013-01

2.  Short communication: factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) at the time of starting combination antiretroviral therapy.

Authors:  Nam Su Ku; Young Goo Song; Sang Hoon Han; Sun Bean Kim; Hye-won Kim; Su Jin Jeong; Chang Oh Kim; June Myung Kim; Jun Yong Choi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-06-25       Impact factor: 2.205

3.  A new prognostic score for AIDS-related lymphomas in the rituximab-era.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Jeannette Y Lee; Lawrence D Kaplan; Josep-Maria Ribera; Albert Oriol; Michele Spina; Umberto Tirelli; Francois Boue; Wyndham H Wilson; Christoph Wyen; Kieron Dunleavy; Ariela Noy; Joseph A Sparano
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

4.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

Review 5.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

6.  Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center.

Authors:  Shikha Garg; Lynn E Taylor; Chris Grasso; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

7.  Sexually transmitted infections among HIV-infected adults in HIV care programs in Kenya: a national sample of HIV clinics.

Authors:  Benson Singa; Sara Nelson Glick; Naomi Bock; Judd Walson; Linda Chaba; James Odek; R Scott McClelland; Gaston Djomand; Hongjiang Gao; Grace John-Stewart
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

8.  Bacterial sexually transmitted infections among HIV-infected patients in the United States: estimates from the Medical Monitoring Project.

Authors:  Elaine W Flagg; Hillard S Weinstock; Emma L Frazier; Eduardo E Valverde; James D Heffelfinger; Jacek Skarbinski
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

9.  Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.

Authors:  Catherine R Lesko; Weiqun Tong; Richard D Moore; Bryan Lau
Journal:  AIDS Behav       Date:  2017-04

10.  Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.

Authors:  Rémi Goupil; Soumeya Brachemi; Annie-Claire Nadeau-Fredette; Clément Déziel; Yves Troyanov; Valery Lavergne; Stéphan Troyanov
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.